Novartis' drug ianalumab meets Phase III endpoints in Sjögren's disease trials, potentially offering the first targeted therapy for this chronic autoimmune disorder.
AI's rapid advancement drives widespread job losses across tech and non-tech sectors, as knowledge work and even creative roles become vulnerable to automation.
Tropical Storm Erin expected to intensify into a major hurricane, with uncertainty around its exact path beyond the five-day forecast period.
Novartis' drug ianalumab meets Phase III endpoints in Sjögren's disease trials, potentially offering the first targeted therapy for this chronic autoimmune disorder.
AI's rapid advancement drives widespread job losses across tech and non-tech sectors, as knowledge work and even creative roles become vulnerable to automation.
Tropical Storm Erin expected to intensify into a major hurricane, with uncertainty around its exact path beyond the five-day forecast period.